BioNexus Gene Lab Corp
NASDAQ:BGLC
BioNexus Gene Lab Corp
NASDAQ:BGLC
Price:
2.14
USD
5.42%
Market Closed
Market Cap:
$3.9m
Balance Sheet
Balance Sheet Decomposition
BioNexus Gene Lab Corp
BioNexus Gene Lab Corp
Balance Sheet Decomposition is not available for
BioNexus Gene Lab Corp
BioNexus Gene Lab Corp
Balance Sheet
BioNexus Gene Lab Corp
BioNexus Gene Lab Corp
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
1
|
0
|
1
|
1
|
1
|
3
|
2
|
|
| Cash |
1
|
1
|
0
|
1
|
1
|
1
|
3
|
2
|
|
| Total Receivables |
0
|
0
|
0
|
4
|
3
|
3
|
1
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
4
|
3
|
3
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
1
|
0
|
2
|
2
|
2
|
3
|
3
|
|
| Total Current Assets |
1
|
1
|
1
|
8
|
7
|
6
|
8
|
7
|
|
| PP&E Net |
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
|
| Total Assets |
1
N/A
|
2
+30%
|
1
-25%
|
10
+723%
|
10
-5%
|
9
-9%
|
11
+30%
|
10
-8%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
0
|
0
|
3
|
2
|
2
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
0
|
0
|
3
|
2
|
2
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
0
-89%
|
0
-15%
|
3
+3 036%
|
2
-31%
|
2
-13%
|
2
-16%
|
2
+21%
|
|
| Equity | |||||||||
| Common Stock |
5
|
7
|
6
|
11
|
11
|
11
|
17
|
17
|
|
| Retained Earnings |
0
|
0
|
0
|
1
|
2
|
1
|
2
|
3
|
|
| Additional Paid In Capital |
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Equity |
0
N/A
|
2
+1 589%
|
1
-26%
|
7
+495%
|
7
+8%
|
7
-7%
|
10
+45%
|
8
-14%
|
|
| Total Liabilities & Equity |
1
N/A
|
2
+30%
|
1
-25%
|
10
+723%
|
10
-5%
|
9
-9%
|
11
+30%
|
10
-8%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
